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Abstract
Entry into mitosis is accompanied by dramatic changes in cellular architecture, metabolism and gene expression. Many
viruses have evolved cell cycle arrest strategies to prevent mitotic entry, presumably to ensure sustained, uninterrupted viral
replication. Here we show for human cytomegalovirus (HCMV) what happens if the viral cell cycle arrest mechanism is
disabled and cells engaged in viral replication enter into unscheduled mitosis. We made use of an HCMV mutant that, due
to a defective Cyclin A2 binding motif in its UL21a gene product (pUL21a), has lost its ability to down-regulate Cyclin A2
and, therefore, to arrest cells at the G1/S transition. Cyclin A2 up-regulation in infected cells not only triggered the onset of
cellular DNA synthesis, but also promoted the accumulation and nuclear translocation of Cyclin B1-CDK1, premature
chromatin condensation and mitotic entry. The infected cells were able to enter metaphase as shown by nuclear lamina
disassembly and, often irregular, metaphase spindle formation. However, anaphase onset was blocked by the still intact
anaphase promoting complex/cyclosome (APC/C) inhibitory function of pUL21a. Remarkably, the essential viral IE2, but not
the related chromosome-associated IE1 protein, disappeared upon mitotic entry, suggesting an inherent instability of IE2
under mitotic conditions. Viral DNA synthesis was impaired in mitosis, as demonstrated by the abnormal morphology and
strongly reduced BrdU incorporation rates of viral replication compartments. The prolonged metaphase arrest in infected
cells coincided with precocious sister chromatid separation and progressive fragmentation of the chromosomal material.
We conclude that the Cyclin A2-binding function of pUL21a contributes to the maintenance of a cell cycle state conducive
for the completion of the HCMV replication cycle. Unscheduled mitotic entry during the course of the HCMV replication has
fatal consequences, leading to abortive infection and cell death.
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Introduction
HCMV (also referred to as human herpesvirus-5, HHV5) is
widely distributed in the human population. Acute HCMV
infection can cause severe complications in immunocompromised
individuals, like neonates, transplant recipients and AIDS patients.
Persistent HCMV infection has been implicated as a contributing
factor in the complex etiology of chronic disorders like inflamma-
tory bowel disease, atherosclerosis and cancer [1,2]. Treatment of
HCMV is limited by severe side effects of available virostatics and
by the emergence of resistant strains [3].
At the cellular level, HCMV can establish either a latent or lytic,
productive infection, depending on the cell type and differentiation
status. Lytic HCMV infection is accompanied by dramatic
changes in host cell physiology, which are induced by the virus
to promote its replication and dissemination. To this end HCMV
has evolved an arsenal of regulatory factors that interact with
central control mechanisms of the host cell. Besides metabolic
pathways [4], cell death programs [5], intrinsic and innate
immune responses [6], one of the main targets of HCMV is the
cell division cycle [7], whose proper function is essential for the
maintenance of genomic stability and cell growth control.
Progression through the somatic cell cycle relies on the periodic
activation of cyclin-dependent kinases (CDKs) [8]. Fundamental
to this periodicity is the temporal and spatial regulation of cyclin
proteins, which are required for both CDK activation and
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substrate recognition. In brief, mitogen-dependent induction of
Cyclin D1–CDK4/6 activity in the early stages of the cell cycle
(G1-phase) leads to phosphorylation of the retinoblastoma protein
(pRb) family of transcription factors and hence to a de-repression
of growth-promoting, pRb–E2F-controlled genes, including those
encoding E, A and B-type cyclins. Increasing levels of Cyclin E1–
CDK2 activity in late G1 trigger S phase entry by further up-
regulation of pRb–E2F-dependent gene expression and by
promoting the process of replication licensing [9,10]. In S phase,
Cyclin E1 is marked for proteolysis by SCF-dependent ubiquitina-
tion [11,12], whilst Cyclin A2 and B1 proteins become stabilized
by inactivation of the APC/C ubiquitin ligase [13]. Cyclin A2–
CDK1/2 activity catalyzes the initiation and regular progression
of cellular DNA synthesis as well as entry into mitosis [14–18].
The importance of Cyclin A2 for the G2/M transition is in large
part due to orchestrating regulatory processes controlling the
major mitosis-promoting factor, Cyclin B1–CDK1 [19–24]. This
complex is held inactive until G2/M transition by inhibitory
phosphorylation of CDK1 and cytoplasmic localization of Cyclin
B1 [23,25]. Once activated, it drives mitosis up and through
metaphase. Further transition to anaphase can only occur after
relief of the spindle checkpoint-mediated restriction of the APC/C.
As a consequence, Cyclin B1 is rapidly destructed to allow mitotic
exit [26]. Evidence from conditional knockout mice suggested that
CDK1 has a ubiquitous essential role for cell division [27]. Cyclin
A2 is essential in embryonic and hematopoietic stem cells but not
in mouse embryonic fibroblasts where its loss can be compensated
by E-type cyclins [28]. On the other hand, combined conditional
knockout of Cyclin A2 and CDK2 is sufficient to impair fibroblast
proliferation [29]. This correlates with the non-overlapping role of
Cyclin A2 in many cultured somatic cell lines [14–18,19–24,30].
HCMV disturbs the regular order of events in the cell cycle
control machinery. It represses Cyclin D1 [31] and instead
employs viral gene products to achieve pRb hyperphosphorylation
[32,33] and E2F target gene activation [34]. It induces Cyclin E1-
CDK2 activity [35–38] but at the same time inhibits replication
licensing [39–41]. It inhibits the APC/C ubiquitin ligase leading
to the accumulation of numerous APC/C substrate proteins
including Cyclin B1 [42–44]. However, HCMV blocks expression
of the APC/C substrate Cyclin A2 [44–46]. Moreover, Cyclin B1-
CDK1, although expressed and activated, is retained to the
cytoplasm unable to trigger mitotic entry [47]. The net effect of
these HCMV-induced alterations is a unique cell cycle state,
characterized by a block of cellular DNA synthesis and cell
division in the presence of a fully induced nucleotide metabolism
as well as up-regulated replication and repair factors. Such
conditions are considered to be most favorable for efficient
replication of the HCMV genome [7,48,49].
Before HCMV can take control over the cell cycle, it is itself
subjected to cell cycle-dependent regulation [50]. In the pre-
immediate early phase of infection, i.e. the time between virus
entry and de novo expression of viral gene products, HCMV is
blocked by Cyclin A2-CDK2 activity [51,52]. This block relies on
a Cyclin A2 binding site in the HCMV inner tegument protein
pp150 [53], matching the RXL/Cy consensus motif found in
cellular Cyclin A2-CDK substrates and inhibitors [54]. Apparent-
ly, HCMV has acquired this motif to make the incoming virus
particle sensitive to cellular Cyclin A2, thereby restricting the start
of lytic gene expression to cells with low or absent Cyclin A2-CDK
activity like quiescent, differentiated and G1 cells [53]. Besides this
general effect on lytic gene expression, Cyclin A2-CDK interferes
more selectively with expression of the essential IE2-86 kDa
protein [51]. This might be one of the reasons why HCMV
suppresses Cyclin A2 once the lytic gene expression has started
[44–46].
In this study we aimed to deepen our understanding of HCMV-
Cyclin A2 interaction by investigating the cause and consequences of
Cyclin A2 repression during lytic infection. We found that HCMV
encodes a second RXL/Cy motif that targets the highly unstable
pUL21a protein [55] to Cyclin A2, resulting in its proteasomal
destruction. This mechanism turned out to be of crucial importance
for the HCMV-induced cell cycle arrest, preventing the virus from
mitotic entry and resultant abortive infection.
Results
To identify potential HCMV gene products with Cyclin A2
inhibitory function we extended our previous search for Cyclin
A2-interaction motifs in virion components [53] to the whole virus
proteome [56]. We found that the small HCMV early-late protein
pUL21a contains two promising candidate motifs, resembling
already validated RXL/Cy sequences of human Cyclin A2-CDK
substrates and inhibitors (Fig. 1A). In particular, both candidate
motifs possess a bulky hydrophobic residue at either position +1 or
+2 relative to the RXL core. This feature is important for docking
to the hydrophobic patch region in Cyclin A2 [57] and therefore
can serve as a suitable criterion for the identification of candidate
RXL/Cy motifs.
To test if pUL21a can physically interact with Cyclin A2 we
performed a pull-down experiment, employing His-purified
pUL21a as bait. We found that pUL21a-WT was able to
precipitate Cyclin A2 from cell extracts with similar efficiency as
the viral Cyclin A2 substrate pp150 (Fig. 1C). Pull-down of an
RXL-binding deficient Cyclin A2 hydrophobic patch mutant [58]
occurred only at background levels, consistent with a pUL21a-
RXL-dependent recruitment of Cyclin A2. In fact, point mutation
(RXLAXA) of the candidate motif RRLFQ (RXL2) abolished
pUL21a-Cyclin A2 binding, whereas the other candidate motif,
RRLAF (RXL1), was dispensable for this interaction (Fig. 1C).
Cyclin B1, which binds inefficiently to RXL/Cy motifs [59], failed
to co-precipitate with pUL21a (Fig. 1D), further demonstrating
the specificity of pUL21a-Cyclin A2 binding.
Author Summary
Cyclin A2 is a key regulator of the cell division cycle.
Interactors of Cyclin A2 typically contain short sequence
elements (RXL/Cy motifs) that bind with high affinity to a
hydrophobic patch in the Cyclin A2 protein. Two types of
RXL/Cy-containing factors are known: i) cyclin-dependent
kinase (CDK) substrates, which are processed by the CDK
subunit that complexes to Cyclin A2, and ii) CDK inhibitors,
which stably associate to Cyclin A2-CDK due to the lack of
CDK phosphorylation sites. Human cytomegalovirus
(HCMV) has evolved a novel type of RXL/Cy-containing
protein. Its UL21a gene product, a small and highly
unstable protein, binds to Cyclin A2 via an RXL/Cy motif in
its N-terminus, leading to efficient degradation of Cyclin
A2 by the proteasome. Here, we show that this mechanism
is not only essential for viral inhibition of cellular DNA
synthesis, but also to prevent entry of infected cells into
mitosis. Unscheduled mitotic entry is followed by aberrant
spindle formation, metaphase arrest, precocious separa-
tion of sister chromatids, chromosomal fragmentation and
cell death. Viral DNA replication and expression of the
essential viral IE2 protein are abrogated in mitosis. Thus,
pUL21a-Cyclin A2 interaction protects HCMV from a
collapse of viral and cellular functions in mitosis.
HCMV Targets Cyclin A2 to Prevent Mitotic Catastrophe
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PUL21a lacks full consensus (S/T-P-X-K/R) CDK phosphor-
ylation sites and contains only one minimal consensus site (S/T-P)
for CDK and mitogen-activated protein kinases (MAPK)-depen-
dent phosphorylation near the N-terminus (Fig. 1B). Thus, it
resembles Cyclin-CDK inhibitors (p21, p27, p57) rather than
substrates. To investigate whether pUL21a functions as a Cyclin
A2-CDK substrate or inhibitor in vitro, we included the protein in
Cyclin A2 kinase assays, using pp150 as a substrate. We found that
pUL21a severely compromised Cyclin A2-dependent phosphory-
lation of pp150 but was itself only weakly phosphorylated. In
accordance with the pull-down experiment, the pUL21a-RXL2
mutant was completely inert to Cyclin A2-CDK activity (Fig. 1E).
Thus, pUL21a only qualifies as a poor substrate but instead as a
strong competitive inhibitor of Cyclin A2-dependent phosphory-
lation in vitro.
In order to validate the pUL21a-Cyclin A2 interaction under
more physiological conditions, we aimed to co-immunoprecipitate
both proteins from pUL21a-transfected human cells (Fig. 2A). To
improve detection of pUL21a, we stabilized the protein by
MG132-mediated inhibition of the proteasome. Under these
conditions, we were able to co-precipitate a significant fraction of
pUL21a with endogenous Cyclin A2-CDK2 complexes. Like in
the preceding experiments, an intact RXL2 motif was required for
this interaction. The amount of Cyclin A2-bound pUL21a was
increased when using a previously described pUL21a-PRAA
mutant (APCmut), deficient in APC/C binding [42]. This was
most probably due to the higher availability of pUL21a-APCmut
and suggests that Cyclin A2-CDK binding to pUL21a was not
saturated.
When comparing cyclin protein levels of MG132-treated and
untreated cells, it became apparent that in the presence of an
active proteasome, pUL21a transfection resulted in a marked,
RXL2-dependent decrease of Cyclin A2 and an RXL1-dependent
decrease of Cyclin D1 (Fig. 2B). These effects were specific since
Cyclins B1 and E1 were unaffected, and they were similar in
strength as the APC/C binding site-dependent down-regulation of
APC5 [42]. Furthermore, both Cyclin A2 and APC5 mRNA
levels were not influenced by pUL21a (Fig. 2C). Thus, destabilisa-
tion of the Cyclin A2 protein appears to be the primary function
of pUL21a-Cyclin A2 binding in vivo. In addition, the
Figure 1. HCMV-pUL21a interacts with Cyclin A2. (A) Alignment of two putative Cyclin A2-binding sites in pUL21a with validated RXL/Cy motifs
of human Cyclin A2-CDK substrates and inhibitors. Identical residues are highlighted in black, conserved residues in grey, phenylalanine/leucin
residues at positions +1 or +2 relative to the RXL motif in red or yellow. (B) Schematic of pUL21a showing the relative location of RXL sequence
motifs, the APC/C-binding site and a minimal consensus CDK phosphorylation site (SP). (C, D) Recombinant Strep-His-tagged versions of pp150,
pUL21a wild-type (wt), pUL21a-RRLAFARAAF (RXL1mut) and pUL21a-RRLFQARAFQ (RXL2mut) mutants were purified and immobilized to Ni-NTA agarose
beads. The beads were incubated with HEK293 cell lysates containing ectopically expressed HA-Cyclin A2 wildtype (CycA2-wt), HA-Cyclin A2
hydrophobic patch mutant (CycA2-hpm) or HA-Cyclin B1 (CycB1). The input lysates and the pulled down material were analyzed by immunoblotting
(IB) for the presence of pUL21a and HA-tagged cyclins. (E) Cyclin A2-associated kinase activity was immunoprecipitated from HEK293 lysates and
incubated with the substrate protein pp150 and radioactively labeled c-P32-ATP. Where indicated, equal amounts of pUL21a-wt or pUL21-RXL2mut
were added to the reaction, as controlled by Coomassie staining (lower panel, IgG-LC: Immunoglobulin G light chain). The phosphorylation products
were analyzed by autoradiography (upper panel).
doi:10.1371/journal.ppat.1004514.g001
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RXL1-dependent down-regulation of Cyclin D1 pointed to a
distinct function of the other putative cyclin docking motif.
We then set out to investigate the functional consequences of
pUL21a-Cyclin A2 interaction in the context of viral infection. To
this end we introduced the RXL2 mutation into the HCMV
genome by traceless BAC-mutagenesis and analyzed the recom-
binant virus in direct comparison to WT, UL21a deletion
(DUL21a) and UL21a-PRAA mutant (APCmut) viruses. To ensure
a synchronous start of lytic gene expression in infected cells, we
used a high multiplicity of infection (MOI) and fibroblasts that
were arrested in G0/G1 by contact inhibition. Accordingly, except
the G1-specific Cyclin D1, cell cycle factors were barely detectable
at the time of infection (Fig. 3A). Whereas Cyclin D1 expression
was largely unaffected by HCMV infection and all four viruses led
to a strong and sustained induction of Cyclin E1, they markedly
differed with respect to Cyclin A2, Cyclin B1 and APC5 protein
regulation. Both UL21a deletion and RXL2 point mutation
abolished the characteristic block of Cyclin A2 expression
observed in HCMV-WT infected cells. Whereas Cyclin A2
mRNA levels were only slightly elevated (see Fig. 3B), the effect
was most pronounced at the level of protein expression, consistent
with the observed proteasome dependency of Cyclin A2 down-
regulation in pUL21a-transfected cells (Fig. 2). Remarkably, the
RXL2 point mutation resulted in considerably higher peak levels
of Cyclin A2 protein expression than the deletion of the whole
UL21a open reading frame. This may be explained by the fact
that the APC/C inhibitory function of UL21a is not affected by
the loss of Cyclin A2 binding (see APC5 levels in Fig. 3A) and thus
can contribute to Cyclin A2 stabilization. Cyclin A2 induction in
HCMV-UL21a-RXL2mut-infected cells was followed by a strong
up-regulation of Cyclin B1 mRNA and protein expression, most
likely due to Cyclin A2-dependent transcriptional activation of the
Cyclin B1 promoter [23]. Again, the effects of UL21a deletion
were much weaker, hardly exceeding the moderate levels of Cyclin
B1 induction in HCMV-WT-infected cells. Thus, the simulta-
neous loss of Cyclin A2 and APC/C-binding sites in pUL21a
masks the full potential of its Cyclin A2 and B1-directed negative
control function.
We next asked what impact, if any, the increased amounts of
Cyclin A2 and B1 at early-late times of infection have on viral
replication. We found that the UL21a-RXL2 mutation caused a
clear delay of up to 24 h in the overall accumulation of late (pp28,
pp150) gene products. Furthermore, the characteristic late
increase in IE2 protein expression was also suppressed in
HCMV-UL21a-RXL2mut-infected cells (Fig. 3A). This correlated
with an almost fourfold reduction in viral progeny production
compared to HCMV-WT (Fig. 3C).
The changes induced by the loss of pUL21a-mediated control
over Cyclin A2 became more evident when the cell cycle profiles
of infected cells were analyzed. Between 24 and 48 h post
infection, both UL21a deletion and RXL2 mutation caused a
rapid increase in the rate of DNA synthesis, leading to an
accumulation of cells with 4n DNA content (Fig. 4A). This
increase was due to cellular rather than viral DNA replication, as
indicated by BrdU pulse-labeling experiments. Both in HCMV-
WT and HCMV-APCmut-infected cells the sites of BrdU
Figure 2. Interaction with pUL21a leads to Cyclin A2 protein
degradation. HEK293 cells were transfected with the indicated
pUL21a-wt and mutant expression plasmids (pUL21a-PRAA: APCmut)
or an empty vector control. Where indicated, MG132 was added to the
cells at 24 h post transfection. Cells were harvested at 48 h post
transfection and processed for the following assays. (A) Cyclin A2-CDK
complexes were immunoprecipitated (IP) from extracts of transfected,
MG132-treated cells and analyzed by immunoblotting for the presence
of Cyclin A2, CDK2 and HA-pUL21a. (B) Whole cell lysates of transfected
cells were analyzed by immunoblotting for expression of the indicated
proteins. (C) Total RNA preparations of transfected cells were analyzed
by quantitative RT-PCR for Cyclin A2 and APC5 mRNA expression. Error
bars indicate the standard deviations of triplicate samples.
doi:10.1371/journal.ppat.1004514.g002
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incorporation co-localized with pUL44, which is the processivity
factor of the viral DNA polymerase and a well-accepted marker of
ongoing viral DNA replication [60,61]. This restriction of DNA
synthesis to viral replication compartments was overcome in the
majority of HCMV-DUL21a and HCMV-RXL2mut-infected
cells. There, nucleotide incorporation was detected throughout
the nucleus, both in pUL44-positive and negative regions (Fig 4B–
C). The presence of cellular DNA synthesis in these cells was
confirmed by suppressing viral replication with foscarnet (PFA), a
selective inhibitor of herpesviral DNA polymerases. Although PFA
treatment, consistent with published data [62], caused some delay
in S-phase progression, a large number of HCMV-DUL21a and
HCMV-UL21a-RXL2mut-infected cells had doubled their DNA
content after 96 h (Fig. S1). Thus, the pUL21a-Cyclin A2
interaction is essential for the block of cellular DNA synthesis in
HCMV-infected cells.
We then examined whether the Cyclin A2-induced progression
through S-phase is followed by mitotic entry of infected cells. Entry
into mitosis is marked by cell rounding and chromatin conden-
sation and therefore can be readily visualized by phase contrast
microscopy and DAPI staining. Both methods revealed a high
number of mitotic cells at 48 h after infection with the UL21a-
RXL2 mutant virus (Fig. 4C, 5A). To quantitatively assess the
number of mitotic cells, we performed flow cytometry of histone
H3-serine 10 phosphorylation (pH3ser10), a marker of condensed
chromatin. Parallel analysis of DNA content and IE1/2 protein
expression in combination with an appropriate gating strategy
ensured that only single, IE-positive cells were evaluated (Fig. S2).
We found that the percentage of HCMV-UL21a-RXL2mut-
infected cells displaying H3(ser10) phosphorylation increased from
about 20% at day 2 to almost 30% at day 3 before it declined
again to just under 10% at day 5 (Fig. 5B–C). Some cells had
undergone chromatin condensation prematurely, i.e. before
completion of DNA replication (Fig. 5B). In case of UL21a
deletion, the proportion of mitotic cells was also increased
compared to HCMV-WT, but remained constantly below 3%
and showed no signs of premature mitotic entry. This low rate of
mitosis is well supported by the only moderate strength of Cyclin
B1 induction in these cells (Fig. 3A). As it is rather unusual that a
point mutation has a stronger phenotype than a whole gene
knockout, it was important to ensure that cyclin up-regulation and
mitotic entry were not caused by unwanted secondary mutations
in the genome of the UL21a-RXL2-mutant virus. We therefore
repaired the RXL2 mutation and analyzed the cell cycle effects of
the UL21a-RXL2-revertant virus. Cyclin A2 and B1 protein
expression as well as mitotic cell numbers were reverted to
HCMV-WT levels (Fig. S3), demonstrating that the observed
changes are specifically linked to the pUL21a-RXL2 motif. We
concluded that pUL21a-Cyclin A2 interaction is not only required
for the inhibition DNA synthesis in HCMV-infected cells but also
for the inhibition of mitotic entry.
It is important to note that even in case of the RXL2 mutant the
majority of infected, Cyclin A2 expressing cells did not traverse the
G2/M boundary but remained in S/G2. In contrast to the mitotic
cell population, these pH3(ser10)-negative cells appeared to
support viral DNA replication to a reasonable extent as many of
them acquired a greater than 4n DNA content in a PFA-sensitive
manner (Fig. 5B, Fig. S1). This may explain why Cyclin A2 up-
regulation has no stronger effect on virus growth (Fig. 3C).
To test whether the observed effects of UL21a-RXL2 mutation
on cell cycle progression and virus replication are a TB40-specific
phenomenon, we introduced the same mutation in the highly
fibroblast-adapted HCMV strain AD169. Following infection of
confluent fibroblasts, the AD169-UL21a-RXL2 mutant virus
induced similar levels of mitotic entry (Fig. S4A) as the TB40
counterpart (Fig. 5A, Fig. S3B) and also had a similarly moderate
growth defect (Fig. S4B). These results argue against a virus strain
dependency of the UL21a-RXL2mut phenotype.
Under normal circumstances, the duration of mitosis in cultured
fibroblasts is about 1 h. The finding of HCMV-UL21a-RXL2mut-
infected cells remaining at high numbers in mitosis over days
pointed to a blockade or at least a severe prolongation of the
mitotic process. We reasoned that the previously reported
restriction of Cyclin B1-CDK1 activity to the cytoplasm of
HCMV-infected cells [47] might prevent the nuclear envelope
breakdown in late prophase [63]. To test this possibility, we
analyzed the nucleo-cytoplasmic distribution of Cyclin B1-CDK1
and the integrity of the nuclear lamina. As expected, we were able
to confirm the cytoplasmic sequestration of CDK1 by HCMV-
WT. However, we observed a high proportion of CDK1 in the
nuclear fraction of UL21a-RXL2mut-infected cells (Fig. 6A),
suggesting that Cyclin A2 down-regulation by pUL21a is also
responsible for the limited nuclear availability of this essential
mitotic kinase during HCMV infection [47]. Interestingly, when
we checked the nucleo-cytoplasmic distribution of Cyclin A2 and
pUL21a (Fig. S4), we found that Cyclin A2 resembled CDK1 in a
way that nuclear translocation was only possible in the absence of
pUL21a binding. In contrast, pUL21a itself was found in both
cellular compartments. In accordance with the observed nuclear
entry of Cyclin A2, Cyclin B1 and CDK1, chromosome
condensation in mitotic HCMV-UL21a-RXL2mut-infected cells
was accompanied by a loss of the nuclear envelope (Fig. 6B).
Hence, there was no evidence for a block of prophase-prometa-
phase transition.
In order to identify the step in mitosis that is impeded in cells
infected with the UL21a-RXL2 mutant, we next visualized mitotic
figures by fluorescent staining of chromosomes (DAPI), centro-
meres (CENP-A) and the spindle apparatus (a-Tubulin). The
results were clear-cut. At 2 days post infection, the large majority
of mitotic cells had accumulated in metaphase whilst anaphase
and telophase figures were completely absent (Fig. 7A–B). Since in
HCMV-DUL21a-infected cells all mitotic stages were represented,
this metaphase arrest appeared to be a direct consequence of the
still intact APC/C-inhibitory function in pUL21a-RXL2mut.
Remarkably, not all metaphase cells contained a regular, bipolar
mitotic spindle. About one third displayed an aberrant, mono- or
multipolar spindle formation (Fig. 7A–B). This phenomenon was
not specific for the UL21a-RXL2 mutant as it was also observed in
case of the UL21a deletion virus (Fig. 7B). Over time, more and
more of the metaphase-arrested cells acquired additional patho-
logical features and ultimately disintegrated entirely. The most
obvious alteration was the appearance of dispersed chromosomal
material that no longer co-localized with the centromere-
specific histone H3 variant CENP-A (Fig. 7A–B). Whereas the
Figure 3. The pUL21a-RXL/Cy motif is required for Cyclin A2 repression by HCMV. Density arrested human embryonic lung (HEL)
fibroblasts were infected with HCMV reconstituted from TB40-BAC4-wt or derivatives carrying the indicated UL21a mutations. Cells were harvested at
regular intervals and analyzed for viral and cellular gene expression by immunoblotting (A) and ribonuclease protection assay (B). Cell culture
supernatants were analyzed for the number of IE protein-forming units (IU) by virus titration (C). Results are represented as mean values plus standard
deviations of triplicate samples.
doi:10.1371/journal.ppat.1004514.g003
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CENP-A-containing foci were still in contact with the mitotic
spindle, the respective chromosomal material was detached
(Fig. 7A). This indicates that these chromosomes had lost their
centromeric region, most likely as a result of chromosomal
instability. The centromere loss occurred in HCMV-infected cells
as demonstrated by IE1/IE2-costaining (Fig. S6). Thus, a
Figure 4. Cyclin A2 expression relieves the block of cellular DNA synthesis in HCMV-infected cells. (A) Cells were infected as described in
the legend to figure 3. Cell cycle progression was monitored by flow cytometric analysis of cellular DNA content (n = haploid number of
chromosomes). (B) To distinguish cellular from viral DNA replication, infected cells were labeled with BrdU at 48 h post infection (hpi). The sites of
BrdU incorporation were stained by immunofluorescence and compared with the localization of pUL44-containing viral replication compartments,
using confocal microscopy. In the right column, merged images of the middle columns are shown. (C) Quantitative analysis of cells undergoing
cellular and/or viral DNA replication at 48 hpi. Mitotic cells were identified by DAPI co-staining. The results represent at least 200 randomly selected
IE1/2-positive cells.
doi:10.1371/journal.ppat.1004514.g004
Figure 5. Cyclin A2 up-regulation results in mitotic entry of infected cells. Cells were infected as described in the legend to figure 3. (A) At
72 hpi, their morphology was examined by phase-contrast microscopy to detect cell rounding. (B, C) Cells were further stained with propidium
iodide, IE1/IE2-and phospho-histone H3(Ser10)-specific antibodies and analyzed by flow cytometry to determine the proportion of infected cells with
(pre-)mitotic chromosome condensation. The results of one representative experiment (A, B) and of five independent experiments (C) are shown.
doi:10.1371/journal.ppat.1004514.g005
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decomposition of chromosomes appeared to characterize the end-
stage of the aberrant mitotic process induced by UL21a-RXL2-
deficient HCMV.
To examine the structural integrity of mitotic chromosomes in
more detail, we analyzed metaphase spreads of HCMV-UL21a-
RXL2mut-infected cells by various methods. First, we re-applied
CENP-A and DAPI co-staining to confirm the assumed chromo-
somal disintegration. Numerous acentric chromatid fragments
were found dispersed to the periphery of the spreads, whereas the
residual, CENP-A-positive material often clustered in central,
metaphase plate-like structures (Fig. 8). Non-infected, prometa-
phase-arrested control cells, in contrast, showed regular pairs of
sister chromatids and centromeres (Fig. 8, upper panel). The sheer
extent of chromosome shattering in many HCMV-UL21a-
RXL2mut-infected cells (Fig. 8, lower panels) pointed towards a
general, and not a chromosome-specific destruction process.
Giemsa staining revealed further chromosomal abnormalities,
contrasting with the characteristic X-shaped chromosomal ap-
pearance of prometaphase-arrested control cells (Fig. 9A, upper
left panel). Besides chromosomal fragmentation, HCMV-
UL21a-RXL2mut-infected, mitotic cells displayed incompletely
condensed chromosomes (Fig. 9A, magnified view #2) or showed
signs of precocious separation of sister chromatids (Fig. 9A,
magnified view #1). In addition, the extent of chromosomal
fragmentation increased over time and ‘‘pulverized’’ chromosomes
dominated the picture of mitotic cells at 3–4 days post infection
(Fig. 9A, lower panel). Notably, the remaining non-mitotic
HCMV-UL21a-RXL2mut-infected cells appeared at this time
with fully developed viral replication compartments, visible as
dark-stained intranuclear regions. This is in accordance with the
observation of viral DNA replication in the G2-arrested, non-
mitotic subpopulation (Fig. 5B, Fig. S1) and with the only
moderate growth defect of pUL21a-Cyclin A2 binding-deficient
viruses (Fig. 3C). It appears that not Cyclin A2 expression per se
but mitotic entry had deleterious consequences for HCMV-
infected cells.
Chromosome fragmentation is often difficult to distinguish
morphologically from premature, incomplete chromosome con-
densation [64]. To obtain further proof for the presence of
chromosomal breakage and to enable a more quantitative
assessment of the different chromosomal abnormalities, we
performed fluorescence in situ hybridization (FISH) analysis of
Figure 6. Disruption of pUL21a-Cyclin A2 interaction facilitates nuclear translocation of Cyclin B1-CDK1 and nuclear envelope
breakdown in HCMV-infected cells. Cells were infected as described in the legend to figure 3. (A) At 48 hpi, nuclear and cytoplasmic fractions
were prepared and analyzed for the presence of Cyclin B1 and CDK1 protein. The purity of both fractions was controlled by immunoblot detection of
Lamin A/C and b-Tubulin. (B) In parallel, cells were analyzed by immunofluorescence microscopy for markers of chromosome condensation (histone
H3 phosphorylation at serine 10) and nuclear envelope integrity (Lamin A/C). Shown are representative images. All cells were confirmed to be HCMV-
positive by IE1/IE2 antibody co-staining.
doi:10.1371/journal.ppat.1004514.g006
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Figure 7. Lack of Cyclin A2 degradation promotes metaphase arrest, aberrant spindle formation and chromosomal instability in
HCMV-infected cells. Cells were infected with HCMV-wt, HCMV-UL21a-RXL2mut or HCMV-DUL21a. Infected cells were examined by
immunofluorescence microscopy for localization and structural organization of chromosomal material (DAPI staining), centromeres (CENP-A
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two large chromosomes, 1 and 3 (Fig. 9B–C). Incompletely
condensed chromosomes were recognized by their extended
conformation or beads-on-a-string appearance. A clear indication
of chromosome breakage was the random distribution of
chromosome 1 or 3 fragments over the whole metaphase spread.
The whole chromosome FISH analysis confirmed the presence of
both phenotypes. At 2 days post infection, some HCMV-UL21a-
RXL2mut-infected mitotic cells even showed a mixed phenotype
with features of both prematurely condensed and partially
fragmented chromosomes (Fig. 9B), suggesting that in these cells
premature condensation gives way to chromosomal breakage [65].
In support of this view, the percentage of mitotic cells with
fragmented chromosomes almost doubled between 2 and 3 days
post infection (from 34% to 59%), at the expense of cells with
incompletely condensed and normal metaphase chromosomes
(Fig. 9C). Notably, about one third of mitotic cells showed no
major signs of chromosomal damage at day 2 to 3 post HCMV-
UL21a-RXL2mut infection but instead contained precociously
separated sister chromatids (Fig. 9B–C). This points to a
phenomenon called cohesion fatigue, which is often found in cells
arrested or delayed at metaphase [66].
Having completed the initial characterization of virus-induced
mitotic aberrations, we were next interested to gain insight into the
implications of mitotic entry for HCMV replication. First, we
analyzed the consequences for major immediate early proteins IE1
and IE2 (Fig. 10). Both nucleoproteins were easily detectable in
the non-mitotic fraction of HCMV-UL21a-RXL2mut-infected
cells and showed a regular nuclear localization pattern, with IE1
being evenly distributed and IE2 accumulating in viral replication
compartments [67]. In mitotic cells, however, the picture was
dramatically different. Whereas IE1 was found associated with
metaphase chromosomes, as expected from published work
[68,69], IE2 protein expression was below detection limit
(Fig. 10). The lack of this essential viral transcription factor
suggests that virus replication is aborted in mitosis. This was
further supported when we examined the morphology and activity
of viral replication compartments in metaphase-arrested cells
(Fig. 11). Judged on the basis of pUL44 staining, the replication
compartments appeared much smaller compared to interphase
cells and were displaced to the cellular periphery. Moreover, no
incorporation of BrdU was detectable suggesting that viral DNA
synthesis and accordingly progression of the infectious cycle was
stalled. We concluded that the pUL21a-dependent arrest at the
G1/S-transition eventually protects HCMV-infected cells from
entering an abortive mitotic stage in which the virus can neither
replicate nor enable the infected cell to exit from.
Discussion
The antagonism between Cyclin A2-CDK activity and viral
gene expression has been recognized as a characteristic hallmark
of HCMV-cell cycle interactions [7,46,51,52]. Recently, we
discovered that HCMV employs an RXL/Cy motif in the
pp150 tegument protein to sense the cellular Cyclin A2 status
right at the beginning of an infection [51,53]. This sensing
mechanism is required to restrict the onset of IE gene expression to
the G0/G1 phase, where Cyclin A2-CDK is inactive. Here, we
found how HCMV makes use of another RXL/Cy motif in the
early gene product pUL21a to maintain the status of low Cyclin
A2-CDK activity after lytic gene expression has started. This
mechanism is not only required to block cellular DNA synthesis
but ensures that viral replication is not abrogated by entry into
mitosis. Possibly, it also protects pp150 at the stage of virion
assembly from Cyclin A2-CDK-dependent phosphorylation so
that pp150 can support the onset of lytic gene expression in newly
infected G0/G1 cells. Such cooperative action would explain why
the progeny of UL21a-deficient HCMV has a reduced infectivity
despite pUL21a itself is not a component of viral particles [55].
Thus, we suggest that both virus-encoded interactors of Cyclin A2
constitute a control circuitry (Fig. 12) that synchronizes the
HCMV lytic cycle to the cell division cycle in a way that secures
efficient viral growth.
Cyclin A2 destruction is after APC4/5 destruction [42] the
second cell cycle regulatory function ascribed to pUL21a. This
small protein appears to be perfectly designed to confer its own
instability to every protein it binds to. Importantly, we found
(Fig. 3A–B, 6A) that Cyclin A2 down-regulation by pUL21a also
accounts for the only moderate expression of Cyclin B1 and the
previously reported cytoplasmic sequestration of CDK1 in
HCMV-infected cells [47]. Because the APC/C ubiquitin ligase
is required for proteasomal degradation of Cyclin A2 and Cyclin
B1 from M to G1 phase [13], the two functions residing in
pUL21a, APC/C inhibition and Cyclin A2 degradation, inversely
regulate Cyclin A2 and Cyclin B1 abundance (Fig. 13). This leads
to the seemingly paradoxical situation that pUL21a-RXL point
mutation has a much stronger effect on Cyclin A2 and B1
expression (Fig. 3A–B), CDK1 nuclear translocation (Fig. 6A) and
mitotic entry (Fig. 5) of infected cells than deletion of the whole
UL21a open reading frame (Fig. 13). Why has HCMV concen-
trated two potent antagonistic cell cycle activities on the same
protein? Probably, HCMV benefits from stabilization of the many
other APC/C substrates [44,70] and, by integrating a Cyclin A2-
binding motif into the same regulatory module, has found an
elegant way to counteract the negative consequences of increased
Cyclin A2 and B1 stability. Furthermore, it might be beneficial for
virus replication if the APC/C-inhibitory function of pUL21a,
which alone elicits mitotic entry and fatal metaphase arrest, is
balanced by the G1 arrest function of pUL21a-mediated Cyclin
A2 degradation (Fig. 13). Our data do not exclude the existence of
additional mechanisms contributing to Cyclin A2 down-regulation
at the level of transcription [50]. In fact, repression of the Cyclin
A2 promoter in the early phase of infection [46] might account for
the only moderate effect of pUL21a-RXL mutation on Cyclin A2
protein expression at 24 hpi (Fig. 3A).
Although Cyclin A2 is an important regulator of S phase
[71,72], the necessity of pUL21a-Cyclin A2 interaction for the
inhibition of cellular DNA synthesis in HCMV-infected cells is an
unexpected result. Previous evidence suggested that HCMV
interferes primarily with the process of replication licensing, by
inhibiting the loading of the MCM2-7 helicase complex onto
chromatin [39,41]. Two mechanisms have been proposed: up-
regulation of the cellular licensing inhibitor Geminin [39] and
expression of the viral licensing inhibitor pUL117 [40]. In
addition, a post-licensing inhibition of the MCM2-7 complex by
direct physical interaction between the MCM3 acetylase
MCM3AP and HCMV-IE2 has been reported [73]. Conversely,
low Cyclin A2-CDK activity is known to promote, rather than
constrain, MCM2-7 loading [74–76], arguing against a causative
staining) and mitotic spindles (a-Tubulin). Representative images are shown in (A). Chromosomes lacking centromeres and accordingly have lost
spindle attachment are marked by arrowheads. Quantitative data based on at least 100 mitotic cells per sample are presented in (B). Non-mitotic cells
were not included in this quantitative analysis.
doi:10.1371/journal.ppat.1004514.g007
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Figure 8. Generalized chromosome shattering in HCMV-UL21a-RXL2mut-infected cells. Metaphase spreads from nocodazole-treated,
non-infected cells were subjected to CENP-A immunofluorescence and DAPI staining and compared to equally prepared material of cells 3 days post
HCMV-UL21a-RXL2mut-infection. Representative images are shown.
doi:10.1371/journal.ppat.1004514.g008
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role of pUL21a-Cyclin A2 interaction in the viral inhibition of pre-
replicative complex formation. Only recently, Cyclin A2-MCM7
binding was described to be critical for the S-phase promoting
function of Cyclin A2 [77]. Two scenarios can be considered to
explain the apparent dominance of Cyclin A2 over other virus-
encoded control mechanisms: either the MCM-directed viral
inhibitors alone are not sufficient to maintain a tight and stable
block to the onset of cellular replication or they are negatively
influenced by Cyclin A2 expression.
Notably in this context, Cyclin A2 over-expression [51] as well
as UL21a deletion [78] have been shown to specifically impair
mRNA expression of the essential viral trans-activator and S phase
inhibitor IE2 [38,73]. The causal chain from pUL21a via Cyclin
A2 to IE2 expression and inhibition of cellular DNA synthesis was
confirmed by another report by Caffarelli et al that appeared while
this manuscript was in preparation [79]. Importantly, Caffarelli et
al were able to overcome the negative effects of pUL21a-RXL2
mutation on IE2 expression and virus replication by Cyclin A2
knockdown [79]. In the present study, IE2 protein accumulation at
late times of infection was suppressed by UL21a-RXL point
mutation but only marginally affected by UL21a deletion
(Fig. 3A), correlating well with their different impact on Cyclin
A2 expression and mitotic entry (see above). In fact, with the
elimination of IE2 protein in mitosis (Fig. 10) we discovered a
further level of IE2-specific regulation, contributing to the overall
decrease in IE2 expression of HCMV-UL21a-RXL2mut-infected
cells. Caffarelli et al [79] possibly missed mitotic entry of UL21a
mutant-infected cells because their cell cycle analysis was carried
out at early times of infection (24–48 hpi) and in the presence of
cell cycle-retarding concentrations of phosphonoacetic acid [51].
An exact side-by-side comparison, however, of Cyclin A2-
mediated effects on IE2 and the cell cycle in this and previous
studies is difficult, given that all previous analyses employed the
highly laboratory-adapted strain AD169 [51,78,79] and used
either proliferating [78,79] or Cyclin A2-overexpressing cells [51]
for infection. Here, in contrast, the low-passage endotheliotropic
strain TB40 and growth-arrested cells were used as starting
materials for most experiments. Given that in our cellular system
an AD169-UL21a-RXL2 mutant showed a very similar cell cycle
and virus growth phenotype (Fig. S4) as the corresponding TB40
mutant (Fig. 3C, Fig. 5A), it appears that different host cell
conditions at the time of infection are the most likely explanation
for the more severe growth defects reported for UL21a-RXL and
deletion mutants in the AD169 background [78,79]. Although we
provided clear evidence for an abrogation of viral replication after
entry into mitosis (Fig. 10–11), it appears that the remaining two
thirds of cells in interphase (mainly G2 phase, see Fig. 4–5, Fig. S1)
supported viral DNA replication and release of HCMV progeny to
a reasonable extent. It remains to be determined how distinct
HCMV genotypes and varying infection conditions influence the
actual outcome of pUL21a-Cyclin A2 interaction on IE2
expression and virus growth.
Animal CMVs lack a Cyclin A2-binding site in their pp150
homologues and accordingly can initiate viral gene expression
Figure 9. Precocious separation of sister chromatids and progressive chromosome fragmentation predominate the chromosomal
appearance of HCMV-UL21a-RXL2mut-infected cells. (A) Metaphase spreads from nocodazole-treated, non-infected cells were subjected to
Giemsa staining and compared to equally prepared chromosomal material of HCMV-wt and HCMV-UL21a-RXL2mut-infected cells at 2 to 4 days post
infection (dpi). Where indicated, magnified views of the encircled areas #1 and #2 in the adjacent image of RXL2mut-infected cells are shown. Scale
bars: 5 mm. (B) Metaphase spreads were analyzed by fluorescence in situ hybridization (FISH) using whole chromosome painting probes for
chromosomes 1 and 3. DNA was counterstained with DAPI. Typical examples of cells with intact metaphase chromosomes (IMC), fragmented
chromosomes (FC), incomplete chromosome condensation (ICC) or precocious separation of sister chromatids (PSC) are shown and labeled
accordingly. (C) Quantitative evaluation of FISH analysis based on at least 100 mitotic HCMV-UL21a-RXL2mut-infected cells per sample. Non-mitotic
cells were not included in the analysis.
doi:10.1371/journal.ppat.1004514.g009
Figure 10. Selective down-regulation of IE2 protein in mitotic
cells. Cells were infected with HCMV-UL21a-RXL2mut and analyzed at
72 hpi by confocal immunofluorescence microscopy for the expression
and subcellular localization of IE1 and IE2 proteins. DAPI staining
enabled discrimination of mitotic from non-mitotic cells. Representative
images are shown. The right column displays the merged fluorescence
channels.
doi:10.1371/journal.ppat.1004514.g010
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independent of the host cell cycle state [53]. Except for primate
CMVs, where the Cyclin A2-destabilizing function of pUL21a is
conserved [79], animal CMVs lack also a pUL21a homologue and
therefore, not surprisingly, murine CMV (MCMV) has been found
to induce not only Cyclin E1 but also Cyclin A2-dependent kinase
activity [51]. However, Cyclin A2 up-regulation does not result in
mitotic entry of MCMV-infected cells, which instead become
arrested in G1 and G2 by a yet unknown IE3-dependent
mechanism [80]. Both G1 and G2-arrested cells support MCMV
DNA replication with similar efficiency [80]. This resembles the
situation in HCMV-UL21a-RXL2mut and HCMV-DUL21-
infected G2 cells where PFA-sensitive viral DNA synthesis leads
to a greater than 4n DNA content (Fig. 5B, Fig. S1). Thus, it
appears that animal CMVs have evolved their own, pUL21a-
independent cell cycle arrest mechanisms to prevent mitotic entry,
thereby counteracting the negative consequences that Cyclin A2
up-regulation can have for viral replication.
The removal of pUL21a-dependent Cyclin A2 repression
reveals the full mitogenic potential of HCMV. The UL21a-
RXL-mutant virus was able to force density-arrested fibroblasts to
re-enter the cell cycle, to traverse through S phase and enter
mitosis. The presence of anaphase and telophase figures (Fig. 7B)
even suggested that some cells, infected by the UL21a deletion
virus, were able to divide. Thus, Cyclin A2 provides the missing
link between virus-induced G1/S-promoting [32,34,38,81] and
G2/M-promoting activities [47,82] that alone were unable to
drive cell cycle progression to completion. Of particular interest in
this context is the fact that Hertel and Mocarski have already
Figure 11. Impaired viral DNA replication in mitotic cells. Cells were infected with HCMV-UL21a-RXL2mut and prepared at 48 hpi for
immunofluorescence microscopy. Chromatin condensation (DAPI), localization of viral DNA replication compartments (pUL44) and DNA synthesis
(BrdU) were analyzed and representative images are shown. The right column displays the merged fluorescence channels. Arrows point to the small
pUL44-positive areas in metaphase cells. Scale bars: 5 mm.
doi:10.1371/journal.ppat.1004514.g011
Figure 12. An RXL-based molecular interface between HCMV
and Cyclin A2. The interface consists of two classical Cyclin A2
interaction motifs that have been acquired by viral gene products
pp150 and pUL21a. The tegument protein pp150 is a substrate of Cyclin
A2-dependent phosphorylation and blocks viral gene expression when
Cyclin A2-CDK activity is high. Once viral gene expression has started,
the early-late protein pUL21a blocks Cyclin A2-CDK activity by Cyclin A2
degradation.
doi:10.1371/journal.ppat.1004514.g012
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described a ‘‘pseudomitotic’’ phenotype in the late phase of
HCMV infection. This is characterized by an upregulation of
mitosis-related gene expression and formation of abnormal mitotic
spindles in the presence of an intact nuclear envelope [82]. This
phenotype fits very well to previous findings by Sanchez et al
showing HCMV-mediated activation but also cytoplasmic seques-
tration of the mitotic kinase Cyclin B1-CDK1 [47], whose nuclear
translocation is an absolute prerequisite for nuclear envelope
breakdown in prophase [63]. Considering that Cyclin A2
induction by UL21a-RXL2 mutation overcome these limitations
(Fig. 6), Cyclin A2 clearly appears to be the rate-limiting factor for
mitosis entry in HCMV-infected cells.
Primary, non-transformed cells possess potent surveillance
mechanisms that arrest the cell cycle in response to deregulated
DNA replication [83]. Similarly, entrance into mitosis is blocked if
DNA replication is not completed [84]. Unscheduled cellular
DNA synthesis (Fig. 4) and premature chromatin condensation
(Fig. 5B) in UL21a-RXL-mutant-infected cells indicate that
HCMV overrides these checkpoints, most likely by abrogating
p53 and Chk2-dependent signaling [85,86]. This and the
partitioning of DNA repair enzymes to viral replication compart-
ments predisposes the host cells to the accumulation of DNA
damage [49,87,88]. It is yet unclear to what extent the intrinsic
genotoxicity of HCMV contributes to the severe chromosomal
instability seen after mitotic entry of infected cells. However, it is
remarkable that checkpoint bypass by dual deficiency of p53 and
Chk1 was recently shown to result in a mitotic catastrophe that
closely resembles the extensive fragmentation of chromosomes and
centromeres in HCMV-UL21a-RXL2mut-infected cells [89,90].
An alternative explanation is that the prolonged mitotic arrest
gives rise to the progressively increasing chromosomal damage
seen in these cells [91]. This view is supported by the simultaneous
loss of sister chromatid cohesion in many cells (Fig. 9), which is
also considered as a characteristic result of extended metaphase
arrest [92,93]. Regardless to what extent the different mechanisms
contribute to the severe chromosomal aberrations induced by the
HCMV-UL21a-RXL mutant, the inherent capacity of this virus to
promote both cell cycle progression and genetic instability may
fuel the ongoing discussion about its potential role in cancer
development and progression [94,95].
Materials and Methods
Ethics statement
All procedures involving animals and their care were approved
(protocol class 003-08/13-01/14; number 2170-24-01-13-03) by
the Ethics Committee for Biomedical Research of the University
of Rijeka Faculty of Medicine (Croatia) and were conducted in
compliance with institutional guidelines as well as with national
(Animal Protection Act 135/06 and 37/13; Regulations on the
Protection of Animals Used for Scientific Purposes 55/2013) and
international (Directive 2010/63/EU of the European Parliament
and of the Council of 22 September 2010 on the protection of
animals used for scientific purposes; Guide for the Care and Use of
Laboratory Animals, National Research Council, 1996) laws and
policies. Animals were bred and raised at the Laboratory for
Mouse Breeding and Engineering Rijeka (LAMRI), University of
Rijeka Faculty of Medicine. The authorization for breeding of and
Figure 13. Crosstalk and antagonism between Cyclin A2 and APC/C-inhibitory functions of HCMV-pUL21a. The UL21a gene product
conveys to independent cell cycle activities, inhibition of Cyclin A2-dependent protein phosphorylation and inhibition of APC/C-dependent protein
ubiquitination. Cyclin A2 inhibition, by impinging on Cyclin B1 accumulation and CDK1 nuclear translocation, prevents HCMV-infected cells from
entering mitosis. APC/C inhibition leads to a block of metaphase-anaphase transition (left panel). If the Cyclin A2-inhibitory function is selectively
impaired by UL21a-RXL mutation, the remaining APC/C-inhibitory function favors the accumulation of Cyclin A2, Cyclin B1, nuclear CDK1 and hence
mitotic entry, while anaphase entry is still blocked (middle panel). If both functions are ablated by UL21a knockout, mitotic entry is still possible but
much less efficient. Once in mitosis, the HCMV-DUL21a-infected cells can proceed to ana- and telophase. Green or red arrows represent the net
effects of the indicated HCMV-UL21a variants on G2/M and metaphase/anaphase transitions.
doi:10.1371/journal.ppat.1004514.g013
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experiments on laboratory mice in this facility has been obtained
by the competent national body (Veterinary Department of
the Croatian Ministry of Agriculture – authorization No. HR-
POK-004).
Cells and viruses
Human embryonic lung (HEL) fibroblasts (Fi301, obtained from
the Institute of Virology, Charite´, Berlin, Germany) and human
embryonic kidney (HEK) 293 cells (obtained from the Leibniz
Institute DSMZ – German Collection of Microorganisms and Cell
Cultures, Braunschweig, Germany) were maintained as described
previously [52]. Where indicated, cells were treated with 2.5 mM
MG132 or 50 ng/ml nocodazole (20 h before harvest) or were
labeled with 10 mM 59-bromo-29-deoxyuridine (BrdU) for 1 h
before harvest. Viruses were derived from the HCMV strain
TB40-BAC4 [96] and modified by bacterial artificial chromosome
(BAC) mutagenesis (see below). Viruses were propagated on HEL
fibroblasts and infectious titers were determined as follows.
Fibroblasts were seeded on 6-well plates and grown to confluence.
Then, cells were infected with a series of virus dilutions in 0.5 ml
of growth medium per well. The virus inocula were replaced by
fresh culture medium after an adsorption period of 1 h. Cells were
harvested at 24 hpi by trypsinization, counted with a hemocy-
tometer and permeabilized with ice-cold PBS/80% ethanol for at
least 5 min. After washing with PBS/1% BSA, cells were stained
with an Alexa Fluor 488-conjugated IE1/2-specific antibody
(clone 8B1.2, Merck-Millipore). The percentage of IE-positive cells
was determined by flow cytometry. Only virus dilutions resulting
in 1–10% IE-positive cells were used to calculate virus titers. This
was done by multiplying the percentage of IE-positive cells by total
cell number and dilution factor. For experiments, a multiplicity of
infection (MOI) of 5–10 IE-protein forming units per cell was
used. Fibroblasts were grown to confluence before infection to
synchronize them in early G1 phase.
BAC mutagenesis
A traceless mutagenesis method [97] was used to generate
TB40-UL21a-RXL2mut, AD169-UL21a-RXL2mut, TB40-
UL21a-APCmut and TB40-DUL21a. In brief, a kanamycin
resistance cassette (KanR) was amplified from the plasmid
pEPkanS2 [97], using the primer pairs UL21a-RRLFQmut-fw/
rev, UL21a-PRmutAA-fw/rev, UL21a-del-fw/rev (table 1). The
PCR products were transformed into Escherichia coli GS1783
[97], containing either TB40-BAC4 or AD169-pHB5 (both kindly
provided by Jens von Einem, Ulm, Germany), and selected for
integration of KanR. Subsequently, the KanR was removed by
induction of lRed-recombinase and I-SceI expression. The
HCMV-TB40-UL21a-RXL2 mutation was reverted using the
primer pair UL21a-RRLFQ-revert-fw/rev (table 1). All steps of
BAC mutagenesis were controlled by PCR and sequencing of the
modified region. BACs were prepared and purified over
NucleoBond Xtra-Midi columns (Macherey-Nagel) following the
manufacturer’s instructions. To reconstitute recombinant virus,
the BACs were cotransfected with pp71/pUL82 and Cre
recombinase expression plasmids into HEL fibroblasts by Amaxa
nucleofection (Lonza).
Plasmids
The pUL21a coding sequence was amplified from TB40-BAC4,
using primers UL21a-fw-BamH1 and UL21a-rev-Sal1 (see
table 1). After BamH1/Sal1-mediated insertion into the prokary-
otic expression vector pET-52b(+) (Merck), the resulting construct
pET-52b(+)-UL21a served as template for site-directed inverse
PCR mutagenesis. To introduce the RXL1 and RXL2 mutations,
the 59-phosphorylated primer pairs UL21a-RXL1-ARAAF-BssH/
UL21a-RXL1-rev and UL21a-RXL2-ARAFQ-BssH/UL21a-
RXL2-rev were used. The amplified, nicked plasmids were
incubated with T4 DNA Ligase for 1 h at room temperature
before being transformed into the Escherichia coli strain XL1-
blue. UL21a-WT, UL21a-RXL1mut and UL21a-RXL2mut
cDNAs were subcloned from pET52b(+) into the eukaryotic
expression vector pCI-neo (Promega) in-frame to an N-terminal
triple-hemagglutinin (3HA) epitope tag. To introduce a point
mutation (PRAA) in the APC/C binding site (UL21a-APCmut), the
pCI-neo-3HA-UL21a-WT plasmid was subjected to site-directed
mutagenesis (see above) using the 59-phosphorylated primers
UL21a-APC-AA-NarI and UL21a-APC-rev (see table 1). All
plasmids were confirmed by sequencing and purified by CsCl-
ethidium bromide equilibrium centrifugation.
His-pull down experiments
The pET-52b(+)-derived expression vectors were transformed
into the Escherichia coli strain BL21-CodonPlus (DE3)-RILP
(Stratagene). Recombinant Strep-pUL21a-His and Strep-pp150c-
His proteins were expressed, purified and used for His-pull down
assays as previously described [53], except for the following
modifications: (i) pUL21a expression was induced by addition of
isopropyl-b-D-1-thiogalactopyranoside (IPTG) to a final concen-
tration of 0.5 mM; ii) after binding to Ni-NTA beads, pUL21a
protein was washed 7 times with buffer containing increasing
concentrations (up to 200 mM) of imidazole.
Kinase assays
Kinase assays were performed as described, using recombinant
pp150c as substrate [53]. Where indicated, equal amounts of
either pUL21a-RXL2 or pUL21a-WT protein was added to the
kinase reactions.
Generation of monoclonal pUL21a antibody
Two BALB/c mice were immunized by subcutaneous injection
of 50 mg of purified Strep-pUL21a-His protein in complete
Freund’s adjuvant. After three weeks, two mice were boosted
with 50 mg of the same protein in complete Freund’s adjuvant by
injecting two-third volume subcutaneously and one-third volume
intraperitoneally (i.p.). After two weeks, the sera of both animals
were tested by ELISA for antibody titer against the recombinant
pUL21a immunogen and the better responder was additionally
boosted i.p. with 50 mg of the same protein dissolved in PBS.
Three days later, spleen cells were collected and fused with SP2/O
myeloma cells (ATCC: CRL 1581) at a ratio of 1:1. The cells were
seeded on 96-well tissue-culture plates in 20% Roswell Park
Memorial Institute (RPMI) 1640 medium containing hypoxan-
thine, aminopterine, and thymidine for hybridoma selection.
Supernatants of the generated mother-well cell lines were screened
for antibodies, reactive against pUL21a immunogen by ELISA.
Positive mother 4G12 was further cloned to generate UL21.02 cell
line secreting monoclonal antibodies against pUL21a.
Immunoprecipitations
The pCI-neo-3HA-UL21a expression plasmids were transfected
into proliferating HEK293 cells using the Turbofect reagent
(Fermentas). To stabilize pUL21a, MG132 was added to the cell
culture medium at 24 h post transfection. Cells were harvested at
48 h post transfection and extracted by freezing-thawing in
immunoprecipitation buffer (IPB): 50 mM Tris–Cl pH 7.4,
150 mM NaCl, 10 mM MgCl2, 10 mM NaF, 0.5 mM Na3VO4,
0.5% Nonidet P-40, 10% glycerol, 1 mM dithiothreitol (DTT),
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2 g/ml aprotinin, 1 mM leupeptin, 1 mM Pefabloc. Cyclin A2-
containing protein complexes were immunoprecipitated by
incubating extracts for 2 h with agarose-conjugated Cyclin A2
antibodies (sc-751 AC, Santa Cruz). After 4 washing steps with
IPB, the agarose-bound proteins were analyzed by immunoblot-
ting for the presence of Cyclin A2, CDK2 and HA-tagged
pUL21a.
Subcellular fractionation
Nuclear and cytoplasmic fractions were prepared as described
previously [53].
Immunoblot analysis
Immunoblot analysis was carried out as described [52], using
antibodies against IE1 (6E1, Vancouver Biotech), IE2 (clone 12E2,
Vancouver Biotech), GAPDH (clone 6C5, Santa Cruz), HA
(clones 12CA5 and 3F10, Roche), Cyclin A2 (clone BF683, BD
Biosciences), Cyclin B1 (clone GNS1, Santa Cruz), Cyclin D1
(clone EPR2241, Abcam), Cyclin E1 (clone H-12, Santa Cruz),
CDK1 (PC25, Merck-Calbiochem), CDK2 (clone 55, BD
Biosciences), APC5 (A301-026A, Bethyl Laboratories), Lamin A/
C (clone 636, Santa Cruz), b-Tubulin (clone 2-28-33, Sigma-
Aldrich), pp65 (clone CH-12, Santa Cruz), pp28 (clone 5C3, Santa
Cruz), pp150 (clone XP1, a gift of Bodo Plachter). The Strep-tag
HRP detection kit (IBA Lifesciences) was used to detect bacterially
expressed Strep-pUL21a-His proteins.
Ribonuclease protection assay
Multi-probe ribonuclease protection assays were performed as
described earlier [38]. The template set hCyc2 (BD Biosciences)
was used for in vitro transcription of the radioactively labeled
probe.
Quantitative real-time PCR
Total cellular RNA was prepared, quantified, reverse-tran-
scribed and analyzed by real-time PCR as described [51]. To
determine mRNA expression levels of Cyclin A2, APC5 and
GAPDH, the primer pairs cyclinA2-fw/cyclin A2-rev, APC5-fw/
APC5-rev and GAPDH-fw/GAPDH-rev were used (see table 1).
Flow cytometry
Cells were fixed, permeabilized and co-stained with propidium
iodide and fluorescently labeled antibodies as previously described
[52]. The following antibody combination was used: Alexa Fluor
488-conjugated anti-IE1/2 (clone 8B1.2, Merck-Millipore), anti-
pH3(ser10) (clone 6G3, Cell Signaling) and BD Horizon V450-
conjugated rat anti-mouse IgG1 (clone A85-1, BD Biosciences).
Immunofluorescence microscopy
HEL fibroblasts were grown to confluency on glass coverslips
before infection. After harvest, the cells were washed with PBS,
fixed with 4% paraformaldehyde in PBS, permeabilized with
PBST (PBS, 0.1% Triton X-100, 0.05% Tween 20), blocked and
immunostained essentially as described elsewhere [98]. To enable
immunofluorescence detection of chromosome-bound IE1 in
mitosis (Fig. 6B, Fig. 10, Fig. S5), cells were fixed and permea-
bilized with ice-cold methanol according to Mu¨cke et al [69]. To
enable immunofluorescence microscopy of chromosome spreads,
cells were swelled after harvest in hypotonic buffer (75 mM KCl)
for 15 min at 37uC. Using a Cellspin I centrifuge (Tharmac),
aliquots of 2.56104 cells were then cytocentrifuged at 250 g for
10 min onto a 6 mm66 mm square sample area of Superfrost
Plus glass slides (Thermo Scientific). After attachment, cells were
allowed to dry for 15 min. Subsequently, cells were fixed with 4%
paraformaldehyde for 10 min at room temperature and subjected
to immunostaining. Primary antibodies against CENP-A (clone 3–
19, GeneTex), pH3-ser10 (clone 6G3, Cell Signaling), Lamin A/C
(clone 636, Santa Cruz), a-Tubulin (clone YL1/2, Merck
Millipore), pUL44 (clone CH16, Santa Cruz), IE1/2 (clone
8B1.2, Merck Millipore), IE1 (clone 6E1, Vancouver Biotech)
and IE2 (clone 12E2, Vancouver Biotech) were used. To allow
various combinations of mouse and rat primary antibody clones,
highly cross-absorbed anti-mouse IgG and IgG isotype-specific
antibodies (Life Technologies) were employed as secondary
reagents. For instance, the staining approach used in Fig. 6B
included three different pairs of mouse primary and isotype-
specific secondary antibodies (anti-IE1/2 + anti-mouse IgG2a-
Alexa 488, anti-Lamin A/C + anti-mouse IgG2b-Alexa 594, anti-
pH3-ser10 + anti-mouse IgG1-Alexa 647). Interphase nuclei and
mitotic chromosomes were always counterstained by the use of
49,6-diamidin-2-phenylindol (DAPI). Images were acquired by an
Eclipse A1 laser-scanning microscope, using NIS-Elements soft-
ware (Nikon Instruments). Equal microscope settings and exposure
times were used to allow direct comparison between samples.
Fluorescence in situ hybridization (FISH) and Giemsa
staining
Giemsa staining was performed essentially as described [80].
Fluorescence in situ hybridization (FISH) was performed with
whole chromosome painting (WCP) probes (Metasystems) for
chromosome 1 (spectrum orange-labeled) and chromosome 3
(spectrum green-labeled) following the manufacturer’s instructions
with slight modifications.
Supporting Information
Figure S1 The Cyclin A2 interaction motif of pUL21a
motif is required for viral inhibition of cellular DNA
synthesis. (A) Time schedule. Confluent fibroblasts were infected
with HCMV. At 24 h post infection (hpi), cells were either treated
with 0.5 mM foscarnet (PFA) or left untreated. Cells were
harvested at 24, 48 and 72 hpi and analyzed for IE protein
expression and DNA content by flow cytometry. (B) Cell cycle
profiles of IE-positive cells are shown as DNA histograms. The
positions of G0/G1 and G2/M phase cells are indicated by their
2n and 4n DNA content (n: haploid number of chromosomes).
(TIF)
Figure S2 Flow cytometry gating strategy used to
analyze cell cycle distribution and chromatin condensa-
tion of HCMV-infected cells. Cells were stained with
propidium iodide (PI), an Alexa Fluor 488-conjugated IE1/IE2
antibody and a combination of phospho-Histone H3(Ser10)-
specific primary and BD Horizon V450-conjugated anti-mouse
IgG1 secondary antibodies. The first two-parameter dot plot
displays the forward and sideward light scatter (FSC and SSC)
properties of flow cytometric events (upper left diagram). A region
(P1) was set that excludes cellular debris and larger cell aggregates
from further analysis. On a second dot blot (upper right diagram),
cells from the P1 region were analyzed for area (A) and width (W)
values of their PI fluorescence signal (recorded on the PerCP
channel). The region P2 was set to gate out cell doublets. The third
dot plot (middle left diagram) was used to analyze cells from the P2
region for IE1/IE2 protein expression (Alexa Fluor 488 signal,
recorded on the FITC channel). An IE-positive cell population was
defined by region P3. On the final dot plot (middle right diagram),
cells from P3 were analyzed for DNA content (PI signal, recorded
on the PerCP channel) and Histone H3-serine 10 phosphorylation
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(V450 signal, recorded on the Pacific Blue channel). The region P4
was set to calculate the percentage of IE-positive cells with
condensed chromatin (H3-serine 10-positive fraction). Cells from
the P4 region were highlighted in red, also within the parental
regions. The gating hierarchy as well as the absolute and relative
number of events in the four defined regions are displayed in the
lower left table. The lower right panel shows the DNA histogram
of IE-positive cells from region P3.
(TIF)
Figure S3 Upregulation of Cyclins A2 and B1 as well as
the induction of mitosis are specific consequences of the
pUL21a-RXL2 point mutation. The HCMV-TB40-UL21a-
RXL2 revertant virus (RXL2rev) was compared to the parental
wild type (wt) and UL21a-RXL2-mutant (RXL2mut) viruses with
regard to Cyclin A2 and B1 protein expression and mitotic
chromatin condensation. (A) Immunoblot analysis of whole cell
lysates 48 h and 72 h after infection of density-arrested fibroblasts.
(B) Flow cytometry of cellular DNA content and Histone H3-
serine 10 phosphorylation at 72 h post infection. According to the
gating strategy in Fig. S1 only the results of IE-positive cells are
shown.
(TIF)
Figure S4 The effects of UL21a-RXL2 mutation on cell
cycle progression and virus growth are not HCMV strain
specific. Density arrested fibroblasts were infected with HCMV-
AD169-UL21a-RXL2mut (MOI = 5). (A) Cells were harvested at
regular intervals and analyzed by flow cytometry for DNA content,
IE1/IE2 expression and histone H3(ser10) phosphorylation accord-
ing to Fig. S2. Shown are DNA/pH3(ser10) dot plots of IE1/IE2
positive cells at 3 dpi when the number of mitotic, pH3(ser10)-
positive events reached a maximum; n: haploid number of
chromosomes. (B) At the indicated time points, cell culture
supernatants were analyzed in biological triplicates for the number
of IE protein-forming units (IU) by virus titration. Mean values and
standard deviations are indicated in the virus growth curves.
(TIF)
Figure S5 Analysis of nucleo-cytoplasmic distribution of
pUL21a and Cyclin A2. Density arrested human embryonic
lung fibroblasts were infected with HCMV reconstituted from
TB40-BAC4-wt or derivatives carrying the indicated UL21a
mutations. To facilitate detection of pUL21a and Cyclin A2, the
proteasome inhibitor MG132 was added at 48 hpi to a final
concentration of 2.5 mM. Nuclear and cytoplasmic fractions were
prepared and analyzed by immunoblotting for the presence of
Cyclin A2, pUL21a, Lamin A/C (nuclear marker) and b-Tubulin
(cytoplasmic marker). The wt and mutant forms of pUL21a were
found to be expressed at similar levels and to be present in both
nuclear and cytoplasmic fractions. Nuclear localization of Cyclin
A2 was dependent on the absence of an intact pUL21a -RXL2
motif.
(TIF)
Figure S6 Loss of centromeres occurs in HCMV-UL21a-
RXL2mut-infected cells. Fibroblasts were seeded on coverslips
and grown to confluence. Subsequently, cells were infected with
HCMV-wt or HCMV-UL21a-RXL2mut as indicated. At 72 hpi
cells were fixed with methanol and examined by immunofluores-
cence microscopy for DNA (DAPI staining), IE gene expression
(IE1/2 staining) and localization of centromeres (CENP-A
staining). Representative images are shown. All visible cells are
IE-positive. Condensed chromosomal material lacking centro-
meres and accordingly has accumulated at the periphery of mitotic
cells is marked by arrowheads.
(TIF)
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